Physician profile
Brian A Stolley
NPI 1649219437
$125,750.51
in general payments reported to CMS, 2019-2025
10 companies · $26K in 2025
The $26K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $1,072 · 2021: $5,198 · 2022: $25K · 2023: $31K · 2024: $25K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $70K · Travel and Lodging: $6,721 · Food and Beverage: $4,079 · Consulting Fee: $1,360 · Education: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $69,573.90 |
| Travel and Lodging | $6,720.71 |
| Food and Beverage | $4,079.42 |
| Consulting Fee | $1,360.00 |
| Education | $346.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $76,204.05 | 2023-2025 | Botox |
| Allergan, INC. | $42,222.98 | 2019-2022 | |
| Galderma Laboratories, L.P. | $6,130.97 | 2019-2025 | |
| Merz North America, INC. | $826.02 | 2019-2025 | |
| Horizon Therapeutics Plc | $127.30 | 2021 | |
| Celgene Corporation | $64.58 | 2019 | |
| Novartis Pharmaceuticals Corporation | $50.45 | 2019 | |
| Ucb, INC. | $50.00 | 2019 | |
| Biofrontera INC. | $49.59 | 2023 | Ameluz, Xepi, Bf-Rhodoled |
| Exact Sciences Corporation | $24.57 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Stolley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.